Strathmann, F.G., et al. (2014) Blood-Based Biomarkers for Traumatic Brain Injury: Evaluation of Research Approaches, Available Methods and Potential Utility from the Clinician and Clinical Laboratory Perspectives. Clinical Biochemistry, 47, 876-888.
https://doi.org/10.1016/j.clinbiochem.2014.01.028

has been cited by the following article:

• TITLE: Detection of the Severity of Brain Injury in Head Trauma Patients Using Biochemical Blood Markers and Its Correlation with Glasgow Coma Scale

  AUTHORS: Mohamed A. Ragaee, Nagwa M. Ghandour, Randa T. Hanna

  KEYWORDS: Brain Injury, Visfatin, Biomarkers, Head Trauma

  JOURNAL NAME: Open Journal of Modern Neurosurgery, Vol.9 No.3, July 31, 2019

  ABSTRACT: Head trauma is one of common injury related mortality and morbidity. Blood biomarkers are valuable tools for the identification and characterization of initial injury and secondary pathological processes for traumatic brain injury (TBI). This study evaluated the performance of a recently developed visfatin and its correlation with other blood circulating biomarkers that reflect specific pathological mechanisms including neuro inflammatory, neuron injury and oxidative damage in moderate to severe TBI patients. Peripheral blood was taken from TBI patients (n = 78) at hospital admission, maximum 6 hours post-injury. Severity and neurological outcome were assessed using the Glasgow Coma Scale (GCS) and blood level of: visfatin, neuron specific enolase (NSE), malondialdehyde (MDA), superoxide dismutase (SOD) and glutathione (GSH). Concentrations of visfatin (28 ± 1.68 μg/L, 25 ± 2.09 μg/L) was significantly higher (p